Sanatan Saraf
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Otorhinolaryngology top 1%
- Head and Neck Cancer Studies
Papers in
- Oncology 20
- Cancer Immunotherapy and Biomarkers 18
- Lung Cancer Research Studies 3
-
- Head and Neck Cancer Studies 4
- Co-authors
- Emilie M.J. van Brummelen (6 shared papers)Patrick Alexander Ott (6 shared papers)Sarina Anne Piha-Paul (8 shared papers)Anne Morosky (4 shared papers)Bilal Piperdi (3 shared papers)Elena Élez (5 shared papers)Christophe Le Tourneau (4 shared papers)Juanita Suzanne Lopez (5 shared papers)
- Journals
- Annals of Oncology (9 papers)Journal of Clinical Oncology (5 papers)Journal of Thoracic Oncology (4 papers)The Lancet Oncology (2 papers)Lung Cancer (2 papers)
- Partner nations
- United StatesTaiwanSouth Korea
In The Last Decade
Sanatan Saraf
30 papers receiving 4.5k citations
Sanatan Saraf's Hit Papers
Peers
Comparison fields: 5 of 78
- Oncology 2.6k
- Otorhinolaryngology 281
- Obstetrics and Gynecology 334
- Pulmonary and Respiratory Medicine 1.1k
- Immunology 642
Countries citing papers authored by Sanatan Saraf
This map shows the geographic impact of Sanatan Saraf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanatan Saraf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanatan Saraf more than expected).
Fields of papers citing papers by Sanatan Saraf
This network shows the impact of papers produced by Sanatan Saraf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanatan Saraf. The network helps show where Sanatan Saraf may publish in the future.
Co-authors
The 25 scholars most cited alongside Sanatan Saraf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1–Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial Hit paper breakdown → | 2017 | 437 |
| 2 | Pembrolizumab in Patients With Extensive-Stage Small-Cell Lung Cancer: Results From the Phase Ib KEYNOTE-028 Study Hit paper breakdown → | 2017 | 419 |
| 3 | Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1–Positive Endometrial Cancer: Results From the KEYNOTE-028 Study Hit paper breakdown → | 2017 | 415 |
| 4 | Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial Hit paper breakdown → | 2017 | 383 |
| 5 | Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1–Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study Hit paper breakdown → | 2017 | 373 |
| 6 | 2018 | 297 | |
| 7 | Safety and activity of pembrolizumab in patients with locally advanced or metastatic urothelial cancer (KEYNOTE-012): a non-randomised, open-label, phase 1b study Hit paper breakdown → | 2017 | 282 |
| 8 | 2017 | 264 | |
| 9 | 2017 | 241 | |
| 10 | 2017 | 201 | |
| 11 | 2018 | 181 | |
| 12 | 2019 | 165 | |
| 13 | 2018 | 163 | |
| 14 | 2018 | 152 | |
| 15 | 2020 | 128 | |
| 16 | 2022 | 80 | |
| 17 | 2018 | 77 | |
| 18 | 2018 | 71 | |
| 19 | 2016 | 42 | |
| 20 | 2016 | 40 |
About Sanatan Saraf
Sanatan Saraf is a scholar working on Oncology, Otorhinolaryngology, Pulmonary and Respiratory Medicine, Obstetrics and Gynecology and Surgery, having authored 30 papers that have together received 4.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (18 papers), Lung Cancer Treatments and Mutations (5 papers), Head and Neck Cancer Studies (4 papers), Endometrial and Cervical Cancer Treatments (3 papers), Lung Cancer Research Studies (3 papers), Prostate Cancer Treatment and Research (2 papers), Colorectal and Anal Carcinomas (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (2.6k citations), Otorhinolaryngology (281 citations), Obstetrics and Gynecology (334 citations), Pulmonary and Respiratory Medicine (1.1k citations) and Immunology (642 citations). Sanatan Saraf has collaborated with scholars based in United States, Taiwan and South Korea. Frequent co-authors include Emilie M.J. van Brummelen, Patrick Alexander Ott, Sarina Anne Piha-Paul, Anne Morosky, Bilal Piperdi, Elena Élez, Christophe Le Tourneau, Juanita Suzanne Lopez, Hope S. Rugo and Andrea Varga. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Journal of Thoracic Oncology, The Lancet Oncology and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.